or Try an Advanced Search...

    Specialty Drugs Stocks List

    Symbol Grade Name % Change
    TAK F Takeda Pharmaceutical Company Limited -0.68
    RZLT C Rezolute, Inc. 3.13
    RAPT F RAPT Therapeutics, Inc. -2.42
    PRTC C PureTech Health plc 0.00
    OTLK F Outlook Therapeutics, Inc. 6.14
    ORIC D Oric Pharmaceuticals, Inc. 1.55
    OPCH F Option Care Health, Inc. -0.20
    INZY D Inozyme Pharma, Inc. -2.75
    FNCH F Finch Therapeutics Group, Inc. 1.04
    EIGR F Eiger BioPharmaceuticals, Inc. 0.00
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Care Plans Medical Care Medical Devices
    Related Stock Lists: Biopharmaceutical Biotechnology Life Sciences Medicine Pharmacy Cancer Cancer Treatment Clinical Medicine Immunology Monoclonal Antibody Biology Disease Lymphedema Treatment Of Cancer Abdominal Pain Age Related Macular Degeneration Alzheimer's Disease Antibodies Antineoplastic Drugs Arcturus Therapeutics

    Related ETFs - A few ETFs which own one or more of the above listed Specialty Drugs stocks.

    Symbol Grade Name Weight
    BIS F ProShares UltraShort Nasdaq Biotechnology 6.12
    PBE C PowerShares Dynamic Biotech & Genome 5.07
    IBRN D iShares Neuroscience and Healthcare ETF 4.68
    BBH B Market Vectors Biotech ETF 4.58
    MNTL C Tema Neuroscience and Mental Health ETF 4.26
    View all Specialty Drugs ETFs...
    Compare ETFs
    Compare BBH to MNTL Compare PBE to BBH Compare PBE to MNTL

        Specialty Drugs Stocks Recent News

        Date Stock Title
        May 17 OTLK Q2 2024 Outlook Therapeutics Inc Earnings Call
        May 16 OPCH Option Care Health to Participate in Upcoming Investor Conferences
        May 16 OTLK Outlook Therapeutics, Inc. (OTLK) Q2 2024 Earnings Call Transcript
        May 16 RZLT Rezolute reports Q3 results
        May 16 TAK Takeda Canada Inc. concludes Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for LIVTENCITY® (maribavir) for the treatment of adults with a post-transplant cytomegalovirus (CMV) infection
        May 16 TAK Takeda’s dengue vaccine obtains WHO prequalification
        May 15 OTLK Outlook Therapeutics reports Q2 results
        May 15 OTLK Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update
        May 15 RZLT Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
        May 15 TAK Takeda dengue vaccine gets WHO clearance
        May 14 RAPT Wolfe downgrades RAPT, but still sees "immense" upside potential
        May 14 TAK Update: Scilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent Dispute
        May 14 TAK Scilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent Dispute
        May 14 TAK Scilex wins court approval for Takeda settlement
        May 14 TAK Takeda to Present Oncology Portfolio and Pipeline Data at the 2024 ASCO Annual Meeting
        May 13 TAK Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday?
        May 13 TAK Takeda shells out $100m to license AC Immune’s Phase II Alzheimer’s therapy
        May 13 TAK AC Immune rockets 47% on Alzheimer's therapy deal with Takeda
        May 13 RAPT Here's Why Rapt Therapeutics (RAPT) is Poised for a Turnaround After Losing -52.88% in 4 Weeks
        May 13 OTLK Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5010 as a Treatment for Wet AMD
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Care Plans Medical Care Medical Devices
        Related Stock Lists: Biotechnology Biopharmaceutical Life Sciences Medicine Monoclonal Antibody Cancer Treatment Pharmacy Alzheimer's Disease Autoimmune Disorders Biology Cancer Chemotherapy Clinical Medicine Disease Immune Disorders Immunology Medication Monoclonal Antibodies Oncology S&P 500
        Specialty Drugs

        Specialty drugs are medications that are used to treat complex and chronic conditions, such as cancer, multiple sclerosis, and rheumatoid arthritis. They are typically more expensive than traditional medications and require special handling, storage, and administration. Specialty drugs may also require special monitoring and close follow-up with a healthcare provider.

        Browse All Tags